Chair: Mijke Buitinga
Room: Rijn
09.45 – 10.00 |
Y. Fang (Wageningen), Fasting and postprandial metabolite profiles differed in subjects with high and low liver fat |
---|---|
10.00 – 10.15 |
K.H.M. Roumans (Maastricht) Whole-body insulin sensitivity decreases after 4-week high fructose compared to 4-week high saturated fat consumption in overweight individuals |
10.15 – 10.30 |
E.J. Kemper (Maastricht) Muscle and liver insulin resistance have distinct plasma protein profiles; a proteomics analysis using the Diogenes cohort |
10.30 – 10.45 |
J.H.P.M. van der Velde (Leiden) Associations between chronotype and total body fat, visceral fat, liver fat, and incidence of type 2 diabetes |
10.45 – 11.00 |
J. Brake (Nijmegen) Dual RNA-sequencing to understand host-pathogen interactions in Mycobacterium tuberculosis-infected macrophages from people with diabetes mellitus |
Chair: Martijn Brouwers
Room: IJssel
09.45 – 10.00 |
M. Ajie (Nijmegen), Diabeter Magnesium supplementation attenuates T-cell function in people with type 2 diabetes with low serum magnesium levels |
---|---|
10.00 – 10.15 |
M.R. Boon (Leiden) Differences in inflammatory pathways between Dutch South Asians vs Dutch Europids with type 2 diabetes |
10.15 – 10.30 |
M.C. Dekkers (Leiden) Extracellular vesicles from stressed beta cells mediate monocyte activation and participate to islet inflammation |
10.30 – 10.45 |
M.S.Hendriksz (Nijmegen) Proteome and transcriptome analyses reveal a role for the liver in hypoglycemia-induced inflammation in diabetes |
10.45 – 11.00 |
D. Sun (Maastricht) Methylglyoxal is a mediator of the association between 2-hour plasma glucose, HbA1c and inflammation: The Maastricht Study |
Chair: Wilrike Pasman
Room: Lek
09.45 – 10.00 |
E.L. van den Burg (Leiden) Integration of a periodic fastingmimicking diet program in primary care for type 2 diabetes |
---|---|
10.00 – 10.15: |
I. Habets (Maastricht) Natural daylight through windows as opposed to artificial lighting during office hours improves glucose control and 24h substrate metabolism in type 2 diabetes patients |
10.15 – 10.30 |
I.M. de Hoogh (Leiden) Using multilevel modelling to predict acute glucose responses to contextual factors in people with type 2 diabetes |
10.30 – 10.45 |
C.A.W. Dietvorst (Rotterdam) Early time-restricted eating in diabetes type 2: preliminary results of the e-TIMED trial |
10.45 – 11.00 |
R. Slebe (Amsterdam) The Effect of Preprandial versus Postprandial Physical Activity on Glycaemia: Meta-Analysis of Human intervention Studies |
11.00 – 11.15 |
L.C.A. Drenthen (Nijmegen) Daily unstructured physical activity affects mean glucose, occurrence of hypoglycaemia and glucose variability in people with type 1 diabetes |
Chair: Behiye Ozcan en Marielle Schroijen
Room: Maas
09.45 – 10.15 |
Prof. dr. Antoinette Maassen van den Brink De rol van hormonen bij migraine en diabetes |
---|---|
10.15 – 10.45 |
Prof. dr. Eelco de Koning De klinische uitkomsten, consequenties en mogelijkheden van het eilandjes transplantatie programma |
10.45 – 11.15 |
Prof. dr. Bart Roep Immuuninterventies in de behandeling van diabetes type 1 |
Chair: Miranda Schram
Room: Rijn
11.45 – 12.00 |
J.I.P. van Heck (Nijmegen) Inflammatory markers are elevated in type 1 and type 2 diabetes and linked to long-term complications |
---|---|
12.00 – 12.15 |
E.S. van der Valk (Rotterdam) Prospective relation between long-term glucocorticoid exposure and incident cardiovascular diseases in a large population based cohort: results from the Lifelines cohort study |
12.15 – 12.30 |
M.E. Tushuizen (Leiden) Non-invasive fibrosis scores as prognostic biomarkers of liver events, CV events and all-cause mortality in people with obesity and T2D in the UK: a longitudinal cohort study |
12.30 – 12.45 |
S.Ghatan (Rotterdam) Evaluating the relationship between glycemic control and bone fragility within the UK biobank: observational and Mendelian randomization analyses |
12.45 – 13.00 |
J.A. de Klerk (Leiden) Different classes of circulating small non-coding RNAs are associated with future diabetic kidney disease |
13.00 – 13.15 |
M.A.G. Helmink (Utrecht) Development and validation of a lifetime prediction model of cardiovascular disease in individuals with type 1 diabetes |
Chair: Eva Corpeleijn
Room: IJssel
11.45 – 12.00 |
L.N. Deden (Arnhem) Explaining the effects of GLP-1 in humans: Visualizing GLP-1 receptor expression in vivo by radiolabeled exendin PET/CT |
---|---|
12.00 – 12.15 |
M.D. Pang (Maastricht) The effect of sweeteners and sweetness enhancers on adipose tissue function in individuals with overweight or obesity – A SWEET sub-study. |
12.15 – 12.30 |
S. Kuckuck (Rotterdam) Cortisol and Food Cravings: The Association of Long-term Biological Stress with Long-term Hedonic Eating Tendencies in Patients with Obesity |
12.30 – 12.45 |
R. Lengton (Rotterdam) Increased Glucocorticoid Receptor Sensitivity is associated with Higher Weight in Patients with Obesity |
Chair: Mandy van Hoek
Room: Lek
11.45 – 12.00 |
M. Kotte (Maastricht) 12 weeks of HIIT modify the skeletal muscle clock and mitochondrial respiration in males at risk for developing type 2 diabetes |
---|---|
12.00 – 12.15 |
R.M. van ‘t Spijker (Wageningen) Evaluating the cardiometabolic and intestinal health impact of habitual plant-based meat analogue consumption via a randomized controlled crossover dietary intervention study |
12.15 – 12.30 |
S. Wopereis (Leiden) Personalized lifestyle to prevent, revert and remit type 2 diabetes in primary care practice |
12.30 – 12.45 |
A. Middelweerd (Enschede) Blended lifestyle coaching for people with diabetes type 2 in secondary care: A feasibility study of the Diameter + CooL |
Chair: Sicco Bus
Room: Waal
11.45 – 12.00 |
S.C. Ghijsen (Utrecht) Free flap reconstruction of the diabetic foot: a case-report and research proposal |
---|---|
12.00 – 12.15 |
C.M. Hulshof (Amsterdam) Walking on eggshells: incidence of diabetesrelated foot ulcer recurrence and its association with demographic and physical activity data |
12.15 – 12.30 |
J.J. van Netten (Amsterdam) Falls in people with diabetes and peripheral neuropathy and their association with physical activity and gait quality |
12.30 – 12.45 |
L.E. Vossen (Amsterdam) The effects of custom-made footwear on stability during walking in people with diabetes and peripheral neuropathy |
Chair: Cees Tack & Thomas van Bemmel
Room: Maas
11.45 – 12.15 |
Dr. Giesje Nefs Diabetesstigma en waarom #languagematters |
---|---|
12.15 – 13.15 |
Dr. Inge van Boxelaer ‘Hybrid-Closed-Loop for all’ |
Chair: Marielle Schroijen & Cyril Landstra
Room: Rijn
14.15 – 14.30 |
T. de Winter (Leiden) A 3’UTR eQTL regulates PTEN expression via miRNA binding specifically in beta cells |
---|---|
14.30 – 14.45 |
E. Dekker (Leiden) Enhanced BMP5 signaling is associated with type 2 diabetes and affects insulin secretion in pancreatic β -cells. |
14.45 – 15.00 |
W.M.H.Hoogaars (Groningen) Novel in vivo zebrafish model and beta cell reporters to address whether exocrine malfunction leads to beta cell stress |
15.00 – 15.15 |
A. Muñoz Garcia (LUMC) Single-cell RNA sequencing of human pancreatic islets reveals a role of pancreatic duct cells as mediator of inflammation |
Chair: Thomas van Bemmel
Room: IJssel
14.15 – 14.30 |
E.A.G. Hietbrink (Enschede) Developing Lifestyle Support Tools for People with Type 2 Diabetes and Low Health Literacy: A Participatory Design Approach |
---|---|
14.30 – 14.45 |
R. de Vries & E. Reinders (Eindhoven) The DiaGame Study: Free-Living Data Collection in Patients with Diabetes Using Wearable Devices |
14.45 – 15.00 |
J.C.G. Bak (Amsterdam) DPARD five years later, assessing mortality in diabetes outpatients |
15.00 – 15.15 |
S.A.G. de Vries (Amsterdam) Does size matter? Hospital volume and resource utilization in pediatric diabetes care. |
Chair: Marten Engelse
Room: Lek
14.15 – 14.30 |
B. Rajaei (Leiden) Enrichment of stemcell islets using a clinicallycompliant density gradient separation method |
---|---|
14.30 – 14.45 |
M.C. Tol (Leiden) Incidence of pancreatic injury and post traumatic pancreatic resections in the Netherlands; is there a role for autologous islet transplantation? |
14.45 – 15.00 |
D. de Jongh (Rotterdam) Clinical translation and implementation of a bioartificial pancreas: A qualitative study exploring the perspectives of patients with Type 1 Diabetes |
Chair: Cyril Landstra/jNVDO
Room: Waal
14.15 – 14.30 |
J. Most (Sittard-Geleen) Metabolic and functional improvements 3 months after total knee replacement surgery |
---|---|
14.30 – 14.45 |
O.W.F. Natan (s’Hertogenbosch) A metformin intolerant patient |
14.45 – 15.00 |
L.C.W. Roksnoer (Rotterdam) Two brothers with late-onset Wolfram syndrome |
15.00 – 15.15 |
T.M. Vriesendorp (Zwolle/ Meppel) Euglycemic ketoacidosis complicating treatment with PI3 kinase inhibitor alpelisib, a novel breast cancer drug |
Chair: Helen Lutgers
Room: Maas
14.15 – 14.45 |
A. Kooy (Groningen/Hoogeveen) PIONEER REAL: Real world evidence of oral semaglutide investigated in daily practice – NL |
---|---|
14.45 – 15.00 |
E.J. den Brok (Maastricht) The effect of bolus advisors on glycaemic parameters in adults with diabetes on intensive insulin therapy: a systematic review with meta-analysis |
15.00 – 15.15 |
O.W.F. Natan (Utrecht) Metformin Immediate Release Pellets in Capsule 500 mg (Fasting and Fed) |
15.45 – 16.45 |
Prof. dr. Naveed Sattar Simple or novel biomarkers in cardiometabolic medicine: What are they and what do they tell us Chair: Prof. dr. Liesbeth van Rossum |
---|---|
16.45 – 17.45 |
Prof. dr. Liesbeth van Rossum New insights in diagnostics and treatment of obesity Chair: Eva Corpeleijn |
Chair: Dr. Esther Phielix
18.25 - 18.30 | Introduction |
---|---|
18.30 - 19.00 | Presentations candidates |
Chair: Dr. Mariëtte Boon
19.00 - 19.15 | Opening and winner of the award in 2022 |
---|---|
19.15 - 19.30 | Announcement and lecture by the 2023 awardee |
20.00 | Announcement of the winner of the 38th Gerritzen award |
---|---|
Chair: Matthijs Hesselink
Room: Rijn
09.30 – 09.45 |
K. Hribar (Groningen) Postpartum development of non-alcoholic fatty liver disease in a lean mouse model of gestational diabetes mellitus |
---|---|
09.45 – 10.00 |
E.J. Hammink (Leiden) A microfluidic platform to study single islet insulin secretion |
10.00 – 10.15 |
R.D. Hauck (Leiden) Modelling MODY1 using human pluripotent stem cells |
10.15 – 10.30 |
M.S. van Agen (Leiden) Developing a vascularized islet-on-a-chip model |
Chair: Julia van Heck
Room: IJssel
09.30 – 09.45 |
Nam Bui (Amsterdam) Gut bacterium Intestinimonas improves the host metabolism evidenced via cohort studies and animal intervention |
---|---|
09.45 – 10.00 |
C.F. Snethlage (Amsterdam) The gut microbiome is associated with residual β-cell function and glycemic control in type 1 diabetes |
10.00 – 10.15 |
C.J. Teunis (Amsterdam) Plasma indoles after broad-spectrum antibiotic use in individuals with severely impaired glucose metabolis |
10.15 – 10.30 |
L.M.M. Vliex (Maastricht) The potential of the prebiotic 2’-Fucosyllactose to improve recovery of the gut microbiome after vancomycin antibiotic use |
Chair: Sander Kooijman
Room: Lek I
09.30 – 09.45 |
S.I.J. Nass (Maastricht) Dietary methylglyoxal improves insulin sensitivity and vascular function in high-fat diet-induced type 2 diabetic mice |
---|---|
09.45 – 10.00 |
A.M. Buziau (Maastricht) Hepatic glucokinase regulatory protein and carbohydrate response element binding protein do not explain the fatty liver phenotype in aldolase B deficiency |
10.00 – 10.15 |
J.M. Lambooij (Leiden) The novel plantbased active principle Totum-448 decreases hepatic steatosis and inflammation in diet-induced NAFLD mice |
10.15 – 10.30 |
M. Liu (Amsterdam) The Natural Metabolite 6-halo-tryptophan Ameliorates Adiposity in vivo and Promotes Lipid Catabolism |
Chair: Martijn Brouwers
Room: Waal
09.30 – 09.45 |
J. Verbunt (Maastricht) Bacterial membrane vesicles derived from lean men and men with overweight/obesity elicit different in vitro immunogenic responses in adipocytes |
---|---|
09.45 – 10.00 |
H.J.P. van der Zande (Wageningen) Weight cycling modifies the visceral adipose tissue and liver immune landscape without impacting whole-body insulin resistance in mice |
10.00 – 10.15 |
L. Smeehuijzen (Wageningen) The impact of obesity and insulin resistance on circulating immune markers and monocyte metabolic signatures |
10.15 – 10.30 |
R.C.R Meex (Maastricht) Fetuin B in white adipose tissue induces inflammation and is associated with peripheral insulin resistance in mice and humans |
Chair: Rinke Stienstra
Room: Lek II
09.30 – 09.45 |
C. Andriessen (Amsterdam) Less is more: A process analysis of the optimalisation of medication in older patients with type 2 diabetes mellitus (OMED2) intervention pilot study |
---|---|
09.45 – 10.00 |
S. Tokgöz (Nijmegen) The role of the hypothalamus-pituitary-adrenal axis in the difference in treatment response to GLP-1 receptor agonists in type 2 diabetes |
10.00 – 10.15 |
F.M.M. Beeren (Arnhem) Endoscopic sutured Gastroplasty in Type 2 diabetic, obese patients using the Endomina device – the GATE trial study design |
10.15 – 10.30 |
D.F. de Wit (Amsterdam) The association between food intake and time in euglycaemic range in individuals with Type 1 Diabetes |
Chair: Rinke Stienstra
10.30 - 11.15 |
Prof. dr. Matthijs Hesselink Training to target diabetes, type and timing matter! |
---|---|
Chair: Helen Lutgers
11.45 - 12.30 |
Prof. dr. Coen Stehouwer Prediabetes: why bother? |
---|---|
12.30 - 13.30 | BEST MEETING ABSTRACTS 2023 |